🇺🇸 FDA
Patent

US 8735358

Methods for treating cancer by regulation of tumor necrosis factor-alpha

granted A61KA61K2039/505A61K38/00

Quick answer

US patent 8735358 (Methods for treating cancer by regulation of tumor necrosis factor-alpha) held by The Regents of the University of Colorado, a Body Corporate expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado, a Body Corporate
Grant date
Tue May 27 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K2039/505, A61K38/00, A61P, A61P1/04